$3250 | Single User
$4650 | Site License
$5650 | Global License

Anxiety Disorders Treatment Market, by drug category (SSRIs, TCAs, SNRIs, MAOIs, Anticonvulsants, and Others), therapy (TMS, ECT, CBT, FWS, and Others), and Geography (North America, Europe, Asia Pacific, And Rest Of The World) – Analysis, Share, Trends, Size, & Forecast From 2016 – 2027- COVID- 19 Updated
[Lowest Price Guaranteed: $3,250]

Published by AnalystView: 01 Jul 2020 | 270593 | In Stock
Related Topics: COVID , Pharmaceuticals

Introduction

REPORT HIGHLIGHT

The anxiety disorders & depression treatment market is estimated to represent a global market of USD 16.6 billion by 2019 with growth rate of 2.2%.

Anxiety is defined as an excessive fear of a normal situation or an exaggerated response to a fear. Anxiety is one of the fast spreading disorder across the globe, majorly among young population. However, people often live with anxiety problem for years before they diagnose or treat with the condition which would in turn hamper the market growth to some extent. According to the American Psychiatric Association, anxiety can be categorized into phobias, acute stress disorder, panic disorder, obsessive-compulsive disorder, generalized anxiety disorder, and post-traumatic stress disorder.

Increasing prevalence of anxiety related disorders has led to high clinical urgency for adoption of various therapies and therapeutics available in the market, which is anticipated to fuel growth over the coming years. As per World Health Organization (WHO), anxiety and other form of depressions are one of the most common mental disorders affecting more than 300 million people worldwide. The number is projected to increase at constant rate during the forecast period.

COVID-19 Impact & Recovery Analysis

The proposed report from AnalystView Market Insights suggests three possible forecast scenarios (probable, optimistic, and pessimistic) considering the COVID-19 impact. Our ongoing research analysis amplifies our framework to ensure the inclusion of underlying COVID-19 crisis impact and potential paths forward. The designed report is delivering detailed insights on COVID-19 considering the changes in consumer demand, purchasing patterns, re-routing of the supply chain, and the significant interventions of governments. The updated study provides insights, and forecast, considering the COVID-19 impact on the market.

In terms of drug category, the market is divided into Selective Serotonin Reuptake Inhibitors (SSRIs), Tricyclic Antidepressants (TCAs), Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs), Monoamine oxidase inhibitors (MAOIs), Anticonvulsants, and Others. Among which, SSRIs and SNRIs are contributed to largest market share, capturing almost 60% share of the global market. Furthermore, segments such as beta blockers, SSRIs and others are considered to be the highest growing market segment during the coming years. This upsurge is a consequence of high stress and competitive work environment coupled with unprecedented shift in the lifestyle, such as drinking, smoking, consumption of unhealthy food, etc.

Regionally, developed countries of North America and Europe dominated the market, captured more than 70% share of the global market. Boost in research and development activities by key operating companies to introduce novel anxiety therapeutics and therapies coupled with surge in demand for effective anxiety therapeutics among end-users drives the market growth.

Furthermore, large number of therapeutics under clinical investigation in North America & Europe further support the market growth. For example, Switzerland based Adde Therapeutics initiated multi-centric, double-blinded, Phase II tiral of ADX71149 in adults affected with major depressive disorder in collaboration with Janssen Pharmaceuticals, Inc. These types of initiatives will support the market growth to great extent.

The market size and forecast for each segment has been provided for the period 2016 to 2027, considering 2019 as the base year. The report also provides the compounded annual growth rate (% CAGR) for the forecast period 2021 to 2027 for every reported segment.

The years considered for the study are:

Historical Year – 2016 to 2018

Base Year – 2019

Estimated Year – 2020

Projected Year – 2027

The proposed reports analyse and evaluates the COVID-19 impact, and anticipated change on the future market scenario on this industry, by taking into the account the economic, political, technological, and social, parameters.

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL ANXIETY DISORDERS & DEPRESSION TREATMENT MARKET, BY DRUG CATEGORY

Selective Serotonin Reuptake Inhibitors (SSRIs)

Tricyclic Antidepressants (TCAs)

Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs)

Monoamine oxidase inhibitors (MAOIs)

Anticonvulsants

Others

GLOBAL ANXIETY DISORDERS & DEPRESSION TREATMENT MARKET, BY THERAPY

Transcranial Magnetic Stimulator (TMS)

Electroconvulsive Therapy (ECT)

Cognitive Behaviour Therapy (CBT)

Fischer Wallace Stimulator

Others

GLOBAL ANXIETY DISORDERS & DEPRESSION TREATMENT MARKET, BY REGION

North America

Europe

Asia Pacific

Latin America

Middle East and Africa

Table of Contents
for Anxiety Disorders Treatment Market, by drug category (SSRIs, TCAs, SNRIs, MAOIs, Anticonvulsants, and Others), therapy (TMS, ECT, CBT, FWS, and Others), and Geography (North America, Europe, Asia Pacific, And Rest Of The World) – Analysis, Share, Trends, Size, & Forecast From 2016 – 2027- COVID- 19 Updated

  • TABLE OF CONTENTS

    ANXIETY DISORDER TREATMENT MARKET OVERVIEW

    Study Scope

    Base Year

    Assumption and Methodology

    EXECUTIVE SUMMARY

    Key Market Facts

    Geographical Scenario

    Companies in the Market

    ANXIETY DISORDER TREATMENT KEY MARKET TRENDS

    Market Drivers

    Impact Analysis of Market Drivers

    Market Restraints

    Impact Analysis of Market Restraints

    Market Opportunities

    Market Future Trends

    ANXIETY DISORDER TREATMENT INDUSTRY STUDY

    Company Activity Analysis

    Regulatory Framework Analysis

    Value Chain Analysis

    ANXIETY DISORDER TREATMENT MARKET LANDSCAPE

    Market Share Analysis

    Key Innovators

    ANXIETY DISORDER TREATMENT MARKET – BY DRUG CATEGORY:

    Overview

    Serotonin Reuptake Inhibitors (SSRIs)

    Overview

    Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    Tricyclic Antidepressants (TCAs)

    Overview

    Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs)

    Overview

    Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    Monoamine oxidase inhibitors (MAOIs)

    Overview

    Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    Anticonvulsants

    Overview

    Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    Others

    Overview

    Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    ANXIETY DISORDER TREATMENT MARKET – BY THERAPY:

    Overview

    Transcranial Magnetic Stimulator

    Overview

    Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    Electroconvulsive Therapy (ECT)

    Overview

    Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    Cognitive Behaviour Therapy (CBT)

    Overview

    Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    Fischer Wallace Stimulator

    Overview

    Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    Others

    Overview

    Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    ANXIETY DISORDER TREATMENT MARKET– BY GEOGRAPHY

    Introduction

    North America

    Overview

    Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    S.

    Overview

    Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    Canada

    Overview

    Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    Europe

    Overview

    Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    France

    Overview

    Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    Germany

    Overview

    Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    Rest of Europe

    Overview

    Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    Asia Pacific (APAC)

    Overview

    Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    China

    Overview

    Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    India

    Overview

    Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    Rest of APAC

    Overview

    Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    Rest of the World

    Overview

    Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    Latin America

    Overview

    Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    Middle East and Africa

    Overview

    Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    KEY VENDOR ANALYSIS

    Eli Lily & Company

    Company Overview

    SWOT Analysis

    Key Developments

    Bristol-Myers Squibb Company

    Company Overview

    SWOT Analysis

    Key Developments

    AstraZeneca plc

    Company Overview

    SWOT Analysis

    Key Developments

    Johnson & Johnson

    Company Overview

    SWOT Analysis

    Key Developments

    GlaxoSmithKline

    Company Overview

    SWOT Analysis

    Key Developments

    Pfizer, Inc.

    Company Overview

    SWOT Analysis

    Key Developments

    360 DEGREE ANALYSTVIEW

    APPENDIX

    Research Methodology

    Abbreviations

    Disclaimer

    Contact Us

    SCOPE AND OBJECTIVES

    The objective of this report is to describe the market trends and revenue forecasts for the ANXIETY DISORDER TREATMENT Market for the upcoming years. The report focuses on defining and describing the key influencing factors for the growth of the market. It also offers an in-depth analysis of the market size (revenue), market share, major market segments, different geographic regions, key market players, and premium industry trends.

    The report tracks the major market events including product launches, technological developments, mergers & acquisitions, and the innovative business strategies opted by key market players. Along with strategically analyzing the key micro markets, the report also focuses on industry-specific drivers, restraints, opportunities and challenges in the coil coatings market. The scope of this report covers the ANXIETY DISORDER TREATMENT Market by its major segments, which include the type, end user industry, and the major geographic regions.

    KEY BENEFITS OF THE REPORT:

    Understanding of the strategies that are being adopted by the key players in this market to stay competitive

    Extensive analysis of the key players dominating the competitive landscape of this market

    In-depth analysis of the key factors are propelling the growth of the global market

    Detailed analysis of the geographic region that will witness the strongest growth

    Granular analysis of the current market scenario and the expected market grow

List Of Tables
in Anxiety Disorders Treatment Market, by drug category (SSRIs, TCAs, SNRIs, MAOIs, Anticonvulsants, and Others), therapy (TMS, ECT, CBT, FWS, and Others), and Geography (North America, Europe, Asia Pacific, And Rest Of The World) – Analysis, Share, Trends, Size, & Forecast From 2016 – 2027- COVID- 19 Updated

List of Tables

Table 1 List of Acronyms

Table 2 Key Market Facts, 2014 - 2025

Table 3 Market Drivers: Impact Analysis

Table 4 Market Restraint: Impact Analysis

Table 5 Market Opportunity: Impact Analysis

Table 6 PESTLE Analysis

Table 7 Porter's Five Forces Analysis

Table 8 Company Market Share Analysis

Table 9 Global Anxiety Disorder Treatments Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

Figure 10 Anxiety Disorder Treatments Market, by Drug Category, 2016 – 2027 (USD Million)

Figure 11 Anxiety Disorder Treatments Market, by Therapy, 2016 – 2027 (USD Million)

Figure 12 Anxiety Disorder Treatments Market, by Geography, 2016 – 2027 (USD Million)

Table 13 North America Anxiety Disorder Treatments Market, 2016 – 2027 (USD Million)

Table 14 U.S. Anxiety Disorder Treatments Market, 2016 – 2027 (USD Million)

Table 15 Canada Anxiety Disorder Treatments Market, 2016 – 2027 (USD Million)

Table 16 Europe Anxiety Disorder Treatments Market, 2016 – 2027 (USD Million)

Table 17 France Anxiety Disorder Treatments Market, 2016 – 2027 (USD Million)

Table 18 Germany Anxiety Disorder Treatments Market, 2016 – 2027 (USD Million)

Table 19 Asia Pacific Anxiety Disorder Treatments Market, 2016 – 2027 (USD Million)

Table 20 China Anxiety Disorder Treatments Market, 2016 – 2027 (USD Million)

Table 21 India Anxiety Disorder Treatments Market, 2016 – 2027 (USD Million)

Table 22 Latin America Anxiety Disorder Treatments Market, 2016 – 2027 (USD Million)

Table 23 MEA Anxiety Disorder Treatments Market, 2016 – 2027 (USD Million)

List Of Figures, Charts and Diagrams
in Anxiety Disorders Treatment Market, by drug category (SSRIs, TCAs, SNRIs, MAOIs, Anticonvulsants, and Others), therapy (TMS, ECT, CBT, FWS, and Others), and Geography (North America, Europe, Asia Pacific, And Rest Of The World) – Analysis, Share, Trends, Size, & Forecast From 2016 – 2027- COVID- 19 Updated

List of Figures

Figure 1 Research Methdology

Figure 2 Research Process Flow Chart

Figure 3 Comparative Analysis, by Geography, 2016-2025 (Value %)

Figure 4 Regulatory Framework Analysis

Figure 5 Value Chain Analysis Analysis

Figure 6 Anxiety Disorder Treatments Market, by Drug Category, 2016 – 2027 (USD Million)

Figure 6 Anxiety Disorder Treatments Market, by Therapy, 2016 – 2027 (USD Million)

Figure 7 Anxiety Disorder Treatments Market, by Geography, 2016 – 2027 (USD Million)

Additional Details

Publisher

AnalystView

Publisher Information

AnalystView Market Insights is a market research and consulting firm that adopts a proactive approach to provide the diverse need for accurate and precise market research, custom research, and consulting solutions across geographies and industry verticals. Our company is led by a team of passionate, naturally curious, and strategic thinkers from different industry backgrounds.



These experts are dedicated to creating concrete market data analysis in various industries such as Healthcare, Bulk Chemicals, Semiconductors and Electronics, Foods and Beverages. We strive to develop meaningful and evidence-based research data that helps our clients, empowering organizations and brands of all sizes with strategic analysis, accurate data, and consumer trends.



We aim to be the number one choice for various clients who require credible data to make vital business decisions. We wish to be a trusted and reliable analytics partner to major business organizations.



We understand that critical business decisions can be taken only when verified, authentic information is available. Therefore, our experts work meticulously to provide our clients with the accurate data, so that they need not spend time in verifying it.



It is also our goal to help our clients ignore traditional research methods that require a large amount of capital, manpower, and most important of it all – the time. We know that these factors are precious to a company and always follow the latest research techniques that produce the required result in a short span of time.

Reference

270593 | AV125

Number of Pages

206

Report Format

PDF

AnalystView Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Global Anxiety Partnering 2010-2017
The Global Anxiety Partnering Terms and Agreements since 2010 report provides understanding and acce...
01 Apr 2017 by Current Partnering USD $1,495 More Info
Global Anxiety Partnering 2010-2017
The Global Anxiety Partnering Terms and Agreements since 2010 report provides understanding and acce...
01 Feb 2017 by Current Partnering USD $1,495 More Info
Global Anxiety Partnering 2010-2016
The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and acce...
01 Nov 2016 by Current Partnering USD $1,495 More Info
Global Anxiety Partnering 2010-2016
The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and acce...
01 Oct 2016 by Current Partnering USD $1,495 More Info
Psychotherapeutic Drugs Market: By Type (Antipsychotics, Antidepressants, Antimaniacs, and Anxiety Drugs) & By Geography (Europe, Asia Pacific, North America, Rest of the World)-Forecast (2016-2021)
Psychotherapeutic drugs are used to treat mental illnesses such as extreme mood swings, social withd...
10 Aug 2016 by USD $5,250 More Info
Social Anxiety Disorders (SAD) Global Clinical Trials Review, H2, 2016
Social Anxiety Disorders (SAD) Global Clinical Trials Review, H2, 2016SummaryGlobalData's clinical t...
27 Jul 2016 by Global Data USD $2,500 More Info
Social Anxiety Disorders (SAD) Global Clinical Trials Review, H2, 2016
Social Anxiety Disorders (SAD) Global Clinical Trials Review, H2, 2016SummaryGlobalData's clinical t...
27 Jul 2016 by Global Data USD $2,500 More Info
Panic Attack Treatment Market: By Panic Attacks Type (Generalized Anxiety Disorder, Obsessive-Compulsive Disorder (OCD), Others), By Drug (SSRI, SNRI, and BZD), & By Region-Forecast (2016-2021)
Panic attacks are associated with sudden surge of overwhelming anxiety and fear. Globally, developme...
14 Mar 2016 by USD $5,250 More Info
Anticonvulsants Market: By Disease Treatment (Epilepsy, Migraine, Fibromyalgia, Neuropathic pain, Anxiety, Bipolar disorder), By Drugs type(AMPA, Triazine, Benzodiazepine, Dibenzazepine, Others), & Geography-Forecast (2016-2021)
Anticonvulsants (also commonly known as antiepileptic drugs or as antiseizure drugs) are drugs that ...
22 Feb 2016 by USD $5,250 More Info
Generalized Anxiety Disorder Market: By Therapeutics Type(Antidepressant, Benzodiazepines, Others (Buspirone)) & Geography(Europe, Asia Pacific, North America, Rest of the World)-Forecast (2016-2021)
Generalized anxiety disorder also known as GAD is diagnosed due to excessive anxiety and worry about...
05 Feb 2016 by USD $5,250 More Info

This report is published by AnalystView

AnalystView Market Insights is a market research and consulting firm that adopts a proactive approach to provide the diverse need for accurate and precise market research, custom research, and consulting solutions across geographies and industry verticals. Our company is led by a team of passionate, naturally curious, and strategic thinkers from different industry backgrounds.

These experts are dedicated to creating concrete market data analysis in various industries such as Healthcare, Bulk Chemicals, Semiconductors and Electronics, Foods and Beverages. We strive to develop meaningful and evidence-based research data that helps our clients, empowering organizations and brands of all sizes with strategic analysis, accurate data, and consumer trends.

We aim to be the number one choice for various clients who require credible data to make vital business decisions. We wish to be a trusted and reliable analytics partner to major business organizations.

We understand that critical business decisions can be taken only when verified, authentic information is available. Therefore, our experts work meticulously to provide our clients with the accurate data, so that they need not spend time in verifying it.

It is also our goal to help our clients ignore traditional research methods that require a large amount of capital, manpower, and most important of it all – the time. We know that these factors are precious to a company and always follow the latest research techniques that produce the required result in a short span of time.

Download Free Report Summary PDF

Anxiety Disorders Treatment Market, by drug category (SSRIs, TCAs, SNRIs, MAOIs, Anticonvulsants, and Others), therapy (TMS, ECT, CBT, FWS, and Others), and Geography (North America, Europe, Asia Pacific, And Rest Of The World) – Analysis, Share, Trends, Size, & Forecast From 2016 – 2027- COVID- 19 Updated | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...